Evidence map›Paper›PMID 41348871›Full record

ArticleScience advances2025

Programmable multistep CRISPR gene activation via control of RNA polymerase III termination.

Anupama K Puppala, Andrew C Nielsen, Maureen Regan, Georgina E Mancinelli, Renee F De Pooter, Stephen Arnovitz, Caspian Harding, Michaele McGregor, Nikolas G Balanis, Ryan Clarke and 1 more

Abstract read
In one paragraph

Article in Science advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Anupama K PuppalaSyntax Bio Inc., Chicago, IL 60642, USA.ORCID 0000-0002-9701-7129
Andrew C NielsenSyntax Bio Inc., Chicago, IL 60642, USA.ORCID 0009-0004-5574-1866
Maureen ReganSyntax Bio Inc., Chicago, IL 60642, USA.
Georgina E MancinelliSyntax Bio Inc., Chicago, IL 60642, USA.ORCID 0000-0002-5216-7086
Renee F De PooterSyntax Bio Inc., Chicago, IL 60642, USA.
Stephen ArnovitzSyntax Bio Inc., Chicago, IL 60642, USA.ORCID 0000-0001-5307-8694
Caspian HardingSyntax Bio Inc., Chicago, IL 60642, USA.ORCID 0009-0007-2836-565X
Michaele McGregorSyntax Bio Inc., Chicago, IL 60642, USA.ORCID 0009-0004-6856-8476
Nikolas G BalanisSyntax Bio Inc., Chicago, IL 60642, USA.
Ryan ClarkeSyntax Bio Inc., Chicago, IL 60642, USA.ORCID 0000-0002-3814-5585
Bradley J MerrillSyntax Bio Inc., Chicago, IL 60642, USA.ORCID 0000-0001-5074-3345

Funding

Harnessing multiplexed Cas9 genome editing for sequential genetic manipulations and recording activities in cell lineagesR01GM139894 · NIGMS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MERRILL, BRADLEY J · 2021 to 2024
$1.2M
NIGMS NIH HHS R01 GM139894
6 · The paper itself

Abstract

Although genomes encode instructions for mammalian cell differentiation with rich syntactic relationships, existing methods for genetically programming cells have only modest capabilities for stepwise gene regulation. Here, we develop a sequential genetic system that transcriptionally activates endogenous genes in a preprogrammed, stepwise manner. This system uses the removal of an RNA polymerase III termination sequence to trigger both the transcriptional activation and DNA endonuclease activities of a Cas9-VPR protein, driving progression through a cascade of gene activation events. The system's functionality in human cells, including iPSCs, enables the development of a path for cellular programming by controlling the sequential order of gene activation to influence cellular states.

Indexed as

Clustered Regularly Interspaced Short Palindromic RepeatsCRISPR-Cas SystemsRNA Polymerase IIITranscriptional ActivationGene EditingHEK293 CellsHumansInduced Pluripotent Stem CellsRNA Polymerase III

Identifiers

PMID41348871
PMCPMC12680031

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.